Clinical Trial Update: GSL Synthetase Inhibitor Plus GM-CSF and/ or Immune Checkpoint Inhibitor in Previously Treated High-Risk Neuroblastoma. [EARLY_Phase 1]

View source ↗

Summary

An early-phase clinical trial evaluating a GSL Synthetase Inhibitor in combination with GM-CSF and/or an immune checkpoint inhibitor for previously treated high…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Drugs mentioned

• GM-CSF (granulocyte-macrophage colony-stimulating factor)
• GSL Synthetase Inhibitor
• Immune checkpoint inhibitor

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Neuroblastoma | EARLY_Phase 1 | Status: NOT_YET_RECRUITING